KCT0003016已完成未知
Impairment for the Efficacy and Safety; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial
Kyung Hee University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 55(Year) 至 85(Year)（—）
- 性别
- All
入选标准
- •A person who complain of memory loss and demonstrate a decrease of 1.0 SD or more on CERAD-K (Consortium to Establish a Registry for Alzheimer's Disease-Korean version)
排除标准
- •- People who are currently suffering from schizophrenia or have a history of schizophrenia
- •- People who have major depressive disorders categorized by DSM-V(The Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition)
- •- People who have poor cognitive function and have Alzheimer’s disease, Parkinson’s disease, or stroke. (The diagnosis of Alzheimer’s disease is based on DSM-V)
- •- People who have taken medications for Alzheimer’s disease or other cognitive function problems within 4 weeks prior to the first visit of the study. The examples of the medications are Antipsycotics, Neurodegenerative Disease Drugs, Nootropics & Neurotonics, and tricyclic antidepressant.
研究者
相似试验
进行中（未招募）
1 期
A 12 week study to assess the efficacy and safety of AF-219 in patients with long term coughEUCTR2015-005064-42-GBAfferent Pharmaceuticals, Inc.253
进行中（未招募）
不适用
Safety Study of the iBalance Axial Knee Realignment System (AKRFX)ACTRN12607000422426iBalance Medical Inc.25
进行中（未招募）
1 期
A 12-week study to test lung function in people with COPD.EUCTR2013-004548-44-PLGlaxoSmithKline Research & Development Ltd1,582
进行中（未招募）
不适用
A 12-week study to test lung function in people with COPD.EUCTR2013-004548-44-BGGlaxoSmithKline Research & Development Ltd1,582
进行中（未招募）
1 期
A 12-week study to test lung function in people with COPD.EUCTR2013-004548-44-ROGlaxoSmithKline Research & Development Ltd2,423